Ken Paulus

President and CEO at Prime Therapeutics

Ken Paulus is a transformative leader with more than 30 years’ experience in the health care sector, building strategic partnerships, integrating payment and delivery systems, and implementing consumer-centric health care solutions. As president and CEO of Prime Therapeutics, Paulus is responsible for the strategic direction and operations of one of the nation’s premier total drug management companies, with more than 28 million members in commercial markets and government programs.

Timeline

  • President and CEO

    Current role

View in org chart